An early Moderna COVID‑19 trial has resurfaced six years on, amid ongoing debate over vaccine risks, guidance and public ...

The updated 2024-2025 mRNA COVID-19 vaccine was linked to moderate protection against severe COVID-19 outcomes, including hospitalizations.

Mycobacterial diseases, including tuberculosis (TB), leprosy, and non-tuberculous mycobacterial (NTM) infections, continue to impose a substantial global ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise ...

Receiving the COVID-19 vaccine and booster reduced preeclampsia risk by nearly 60% in pregnant patients with preexisting morbidities.

False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a ...

Even individuals who did not become seriously ill with COVID-19 may have developed a weakened immune system that could lead ...

Ali Sudderth, a 33-year-old woman said that she woke up with "tingly" toes and slowly her entire body became numb and she ...

As the United States emerges from one of the most severe flu seasons it’s seen in nearly three decades, the medical community ...

New Board Appointments and Strategic Partnerships Drive Fresh Momentum Accelerating Expansion into Chinese Medicine and ...

The American Academy of Pediatrics generally recommends RSV immunization for infants under eight months old born during or ...

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or older should receive a protein subunit Respiratory Syncytial Virus (RSV) ...